Aura Biosciences Inc
AURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$450.04M
Close$
$0.70
90.2% downside
Current Fair Value
90.2% downsideOvervalued by 90.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $450.04 Million |
|---|---|
| Enterprise Value | $382.24 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.76 |
| Beta | 0.4 |
| Outstanding Shares | 67,447,576 |
Return
| Return on Equity | -104.80% |
|---|---|
| Return on Assets | -81.64% |
| Return on Invested Capital | 16.53% |
Valuation & Multiples
| P/E Ratio | -3.96 |
|---|---|
| PEG | -17.55 |
| Price to Sales | - |
| Price to Book Ratio | 7.15 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 19.12 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.40%▼ 82.93% |
|---|---|
| Total Invested | $6.70M▼ 98.03% |
| Investors Holding | 20▼ 107.00% |
ESG Score
No data